Tuesday, November 8, 2016

BRIEF-Valeant Pharmaceuticals sees lower 2017 revenue, adj EBITDA

Nov 8 (Reuters) - Valeant Pharmaceuticals International Inc

executives, speaking on a conference call:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)